BullBD Old Apps Site
Home
Favorites
Recently viewed Details Chart Today news Share news Top gainer Top Looser Upcoming events
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0 1 2 3 4 5 6 7 8 9 All
Bank Cement Ceramics Sector Corporate Bond Engineering Financial Institutions Food & Allied Fuel & Power IT Sector Insurance Jute Life Insurance Miscellaneous Mutual Funds Paper & Printing Pharmaceuticals & Chemicals Services & Real Estate Tannery Industries Telecommunication Textile Travel & Leisure All
  • Details
  • Chart
  • News

PHARMAID

All Eps Dividend Board Agm Q1 Q2 Q3

PHARMAID 10-Nov-2022

The Board of Directors has recommended 50% cash dividend for the year ended June 30, 2022. Date of AGM: 27.12.2022, Time: 11:30 AM, Venue: Digital Platform. Record date: 08.12.2022. The Company has reported EPS of Tk. 11.14, NAV per share of Tk. 98.83 and NOCFPS of Tk. 10.85 for the year ended June 30, 2022 as against Tk. 16.11, Tk. 93.26 and Tk. 10.07 respectively for the same period of the previous year. (cont.)

পরিচালনা পর্ষদ 30 জুন, 2022 তারিখে সমাপ্ত বছরের জন্য 50% নগদ লভ্যাংশ সুপারিশ করেছে। এজিএমের তারিখ: 27.12.2022, সময়: 11:30 AM, স্থান: ডিজিটাল প্ল্যাটফর্ম। রেকর্ডের তারিখ: 08.12.2022। কোম্পানিটি টাকা ইপিএস জানিয়েছে। 11.14, শেয়ার প্রতি NAV টাকা 98.83 এবং NOCFPS টাকা 30 জুন, 2022 সমাপ্ত বছরের জন্য 10.85 টাকার বিপরীতে 16.11, টাকা 93.26 এবং টাকা আগের বছরের একই সময়ের জন্য যথাক্রমে 10.07। (চলবে)

PHARMAID 05-May-2022

(Continuation news of PHARMAID): EPS increased due to increase in sales. NOCFPS increased due to increase in collection from revenue and others. NAV increased due to increase in sales and increase in retained earnings. (end)

(PHARMAID-এর ধারাবাহিক খবর): বিক্রি বেড়ে যাওয়ায় ইপিএস বেড়েছে। রাজস্ব এবং অন্যান্য থেকে সংগ্রহ বৃদ্ধির কারণে NOCFPS বৃদ্ধি পেয়েছে। বিক্রয় বৃদ্ধি এবং ধরে রাখা আয় বৃদ্ধির কারণে NAV বৃদ্ধি পেয়েছে। (শেষ)

PHARMAID 05-May-2022

(Q3 Un-audited): EPS was Tk. 4.63 for January-March 2022 as against Tk. 4.12 for January-March 2021; EPS was Tk. 15.31 for July 2021-March 2022 as against Tk. 12.17 for July 2020-March 2021. NOCFPS was Tk. 15.37 for July 2021-March 2022 as against Tk. 9.97 for July 2020-March 2021. NAV per share was Tk. 103.15 as on March 31, 2022 and Tk. 93.26 as on June 30, 2021. (cont.)

(Q3 আন-অডিটেড): ইপিএস ছিল টাকা। জানুয়ারী-মার্চ 2022-এর জন্য 4.63 টাকার বিপরীতে জানুয়ারী-মার্চ 2021 এর জন্য 4.12; ইপিএস ছিল টাকা। 15.31 জুলাই 2021-মার্চ 2022 এর বিপরীতে জুলাই 2020-মার্চ 2021-এর জন্য 12.17। NOCFPS ছিল টাকা। জুলাই 2021-মার্চ 2022 এর জন্য 15.37 টাকার বিপরীতে জুলাই 2020-মার্চ 2021-এর জন্য 9.97। শেয়ার প্রতি NAV ছিল টাকা। 31 মার্চ, 2022 তারিখে 103.15 এবং টাকা 93.26 জুন 30, 2021 পর্যন্ত। (চলবে)

PHARMAID 31-Jan-2022

(Q2 Un-audited): EPS was Tk. 5.53 for October-December 2021 as against Tk. 4.03 for October-December 2020; EPS was Tk. 10.69 for July-December 2021 as against Tk. 8.05 for July-December 2020. NOCFPS was Tk. 14.56 for July-December 2021 as against Tk. 13.89 for July-December 2020. NAV per share was Tk. 98.66 as on December 31, 2021 and Tk. 93.26 as on June 30, 2021.

(Q2 আন-অডিটেড): ইপিএস ছিল টাকা। অক্টোবর-ডিসেম্বর 2021-এর জন্য 5.53 টাকার বিপরীতে অক্টোবর-ডিসেম্বর 2020 এর জন্য 4.03; ইপিএস ছিল টাকা। জুলাই-ডিসেম্বর 2021-এর জন্য 10.69 টাকার বিপরীতে জুলাই-ডিসেম্বর 2020-এর জন্য 8.05। NOCFPS ছিল টাকা। জুলাই-ডিসেম্বর 2021-এর জন্য 14.56 টাকার বিপরীতে জুলাই-ডিসেম্বর 2020 এর জন্য 13.89। শেয়ার প্রতি NAV ছিল টাকা। 31 ডিসেম্বর, 2021 তারিখে 98.66 এবং টাকা 30 জুন, 2021 অনুযায়ী 93.26।

PHARMAID 15-Nov-2021

(Q1 Un-audited): EPS was Tk. 5.15 for July-September 2021 as against Tk. 4.01 for July-September 2020; NOCFPS was Tk. 3.37 for July-September 2021 as against Tk. 1.94 for July-September 2020. NAV per share was Tk. 98.29 as on September 30, 2021 and Tk. 93.26 as on June 30, 2021.

PHARMAID 10-Nov-2021

The Board of Directors has recommended 50% cash dividend for the year ended on June 30, 2021. Date of AGM: 30.12.2021, Time: 11:30 AM, Venue: Digital Platform. Record date: 07.12.2021. The Company has reported EPS of Tk. 16.11, NAV per share of Tk. 93.26 and NOCFPS of Tk. 10.07 for the year ended on June 30, 2021 as against Tk. 16.82, Tk. 82.54 and Tk. 13.04 respectively for the same period of the previous year.

PHARMAID 02-May-2021

(Q3 Un-audited): EPS was Tk. 4.12 for January-March 2021 as against Tk. 4.34 for January-March 2020; EPS was Tk. 12.17 for July 2020-March 2021 as against Tk. 14.31 for July 2019-March 2020. NOCFPS was Tk. 9.97 for July 2020-March 2021 as against Tk. 11.94 for July 2019-March 2020. NAV per share was Tk. 89.45 as on March 31, 2021 and Tk. 82.54 as on June 30, 2020. They have informed that EPS decreased due to increase of expenses in connection with COVID-19.

PHARMAID 31-Jan-2021

(Q2 Un-audited): EPS was Tk. 4.03 for October-December 2020 as against Tk. 5.15 for October-December 2019; EPS was Tk. 8.05 for July-December 2020 as against Tk. 9.77 for July-December 2019. NOCFPS was Tk. 13.89 for July-December 2020 as against Tk. 13.79 for July-December 2019. NAV per share was Tk. 85.41 as on December 31, 2020 and Tk. 82.54 as on June 30, 2020.

PHARMAID 15-Nov-2020

(Q1 Un-audited): EPS was Tk. 4.01 for July-September 2020 as against Tk. 4.63 for July-September 2019; NOCFPS was Tk. 1.94 for July-September 2020 as against Tk. 6.20 for July-September 2019. NAV per share was Tk. 86.47 as on September 30, 2020 and Tk. 82.54 as on June 30, 2020.

PHARMAID 10-Nov-2020

The Board of Directors has recommended 50% cash dividend for the year ended on June 30, 2020. Date of AGM: 24.12.2020, Time: 11:30 AM, Venue: Virtual Platform. Record date: 07.12.2020 The Company has reported EPS of Tk. 16.82, NAV per share of Tk. 82.54 and NOCFPS of Tk. 13.04 for the year ended on June 30, 2020 as against Tk. 15.48, Tk. 71.08 and Tk. 8.05 respectively for the same period of the previous year.

Previous Next page